Developing a digital health solution to allow for remote treatment of migraine.
Migrevention has raised €355k across 1 funding round from 2 investors, most recently a Pre-Seed round in Jan 2022. Based in Tallinn, Estonia; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-03 | Pre-Seed |
| €355k |
| Angel Investors,Dag Nurm |
| View deal → |
